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Background: The existing literature on weight management interventions targeting physical activity and healthy
eating in mental health care appears to provide only limited evidence. The aim of the study was to examine the
effectiveness of a 10-week health promotion intervention, followed by a 6-month follow-up period in individuals
with mental disorders living in sheltered housing in the Flanders region (Belgium).
Methods: The study had a cluster preference randomized controlled design. Twenty-five sheltered housing organisations
agreed to participate (16 in the intervention group, nine in the control group). In the intervention group, 225 individuals
agreed to participate, while in the control group 99 individuals entered into the study. The main outcomes were changes
in body weight, Body Mass Index, waist circumference and fat mass. Secondary outcomes consisted of changes in physical
activity levels, eating habits, health-related quality of life and psychiatric symptom severity.
Results: A significant difference was found between the intervention group and the control group regarding body weight
(−0.35 vs. +0.22 kg; p=0.04), Body Mass Index (−0.12 vs. +0.08 kg/m2; p=0.04), waist circumference (−0.29 vs. + 0.55 cm;
p<0.01), and fat mass (−0.99 vs. −0.12%; p<0.01). The decrease in these outcomes in the intervention group disappeared
during the follow up period, except for fat mass. Within the intervention group, a larger decrease in the primary outcomes
was found in the participants who completed the intervention. No significant differences between the two groups in
changes in the secondary outcomes were found, except for the pedometer-determined steps/day. In the intervention
group, the mean number of daily steps increased, while it decreased in the control group.
Conclusions: The study demonstrated that small significant improvements in the primary outcomes are possible in
individuals with mental disorders. Integration of health promotion activities targeting physical activity and healthy eating
into daily care are, however, necessary to maintain the promising results.
Trial registration: This study is registered at ClinicalTrials.gov NCT 01336946
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Several studies have shown that individuals with mental
disorders (MD) including schizophrenia, bipolar disorders,
depression, and anxiety disorders are at a greater risk of
being overweight (Body Mass Index 25–29.9 kg/m2) or
obese (Body Mass Index ≥30 kg/m2) than the general
population [1-3]. These conditions and other related
metabolic disturbances [4,5] are substantial risk factors for* Correspondence: nick.verhaeghe@ugent.be
1Department of Public Health, Ghent University, Ghent, Belgium
Full list of author information is available at the end of the article
© 2013 Verhaeghe et al.; licensee BioMed Cen
Creative Commons Attribution License (http:/
distribution, and reproduction in any mediumthe high prevalence of cardiovascular disease (CVD) and
associated mortality in this population [6,7].
In people with MD, excessive weight gain has been as-
sociated with the use of especially second generation an-
tipsychotics (SGAs), the degree of which is variable
according to the type of antipsychotic drug used [8,9].
Beside the side effects of these drugs, the high preva-
lence of overweight and obesity in this population is also
associated with lower physical activity (PA) levels and
more unhealthy eating habits. The former include less
moderate or vigorous PA than the general population ortral Ltd. This is an Open Access article distributed under the terms of the
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fruit, vegetables, wholegrain bread and, milk products
less frequently, eating more instant meals [13-15] and
fat [16], and having less variety of food in the diet [17].
Growing attention is being given to lifestyle interven-
tions targeting PA and healthy eating, the effectiveness
of which in the general population is already well
established [18,19]. The current literature on weight re-
duction interventions in mental health care appears to
provide only limited evidence of the effectiveness of ei-
ther psycho-educational programmes or programmes in-
cluding educational and exercise components [20]. More
research is therefore required to examine the effective-
ness of these kinds of interventions in populations of in-
dividuals with MD.
This paper describes the results of a health promotion
intervention targeting PA and healthy eating in individ-
uals with MD living in sheltered housing in the Flanders
region (Belgium). The study consisted of a 10-week
intervention period followed by a 6-month follow up
period.
Methods
Study design and setting
The study design consisted of a cluster preference ran-
domized controlled trial (RCT). The study was conducted
in sheltered housing organisations (SHOs) in the Flanders
region (Belgium), where there were 42 SHOs amounting
to 2662 approved places at the time [21].
In Belgium, sheltered housing is aimed at people with
MD aged 18 years and older who do not need to stay in
a psychiatric inpatient facility on a permanent basis. The
main goal is the psychiatric rehabilitation of the patients
(usually known as ‘residents’). In the rehabilitation
process, patients receive support to develop the emo-
tional, social and intellectual skills needed to live, learn
and work in the community with the lowest amount of
support [22]. In practice, the usual treatment consists of
weekly meetings between the mental health nurse and
the resident to discuss topics such as how to cope with
the psychiatric disease, somatic health, household tasks,
and financial issues. The main objective is to maximize
the personal autonomy of each resident who is encour-
aged to do as much as possible for him/herself including
self-care, shopping, cooking, domestic chores and leisure
time activities with the support of the mental health
nurses. Particular attention is given to the search for a
meaningful daily occupation such as regular or sheltered
employment, or voluntary work.
Residents can live alone or they can live together with
other patients in ‘community houses’. In these settings,
residents have their own bedrooms but share communal
areas such as the kitchen, bathroom and living room.
Both individuals living alone as well as those living in‘community houses’ were eligible for participation. As-
signment to the intervention or control group at the in-
dividual level was not possible because of the high risk
of contamination bias by participants living together in
the same ‘community house’. This risk of bias was
avoided as the assignment to the intervention or control
group occurred at the level of the SHO. Based on the lit-
erature [23,24] on possible problems in the design of
studies evaluating behavioural or psychosocial interven-
tions, it was assumed that being assigned to a non-
preferred intervention condition could reduce the SHOs
interest in participating in the study. For this reason, it
was decided to use a preference design. In this design,
subjects are allowed to select the intervention assign-
ment. This is useful when strong preferences among po-
tential participants threaten either the ability to recruit
an adequate sample size of representative participants or
when such preferences threaten participants’ acceptance
of treatment assignment, adherence or retention in the
trial [25]. In this study, SHOs with strong preferences
were offered their preferred condition, while those with-
out were randomized in the usual way.
Study population and recruitment
The study population consisted of individuals with MD
aged between 18 and 75 years of age living in sheltered
housing in the Flanders region. Exclusion criteria in-
cluded individuals older than 75 years, those fitted with
a gastric ring or pacemaker and those with cognitive im-
pairments which would prevent them being able to fol-
low and understand the psycho-educational and
behavioural sessions of the health promotion interven-
tion (as assessed by the mental health nurses).
Recruitment of participants took place from June 2010
until January 2011. An invitation letter and response
form with a self-addressed stamped envelope was sent to
the administrators of all SHOs in the Flanders region.
The letter included a concise explanation of the aim of
the study and the expectations and content if an organ-
isation was willing to serve as intervention group. The
administrators were asked to discuss the study proposal
with their staff to decide whether they were interested in
participating. Involving the staff members in the decision
process was considered important because, if an organ-
isation was willing to serve as intervention group, one or
more mental health nurses would be involved in the
intervention. They were asked if they were interested in
participating in the study with (i) no preference to serve
as intervention or control group and to be randomized
or, (ii) a preference to serve as intervention group or,
(iii) a preference to serve as control group. SHOs which
did not respond after six weeks were sent a reminder.
SHOs which were not prepared to participate were
asked to report the reason for non-participation. The
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sult the residents in the decision process.
Based on responses to the letter, the SHOs were subse-
quently either assigned to the intervention group or con-
trol group according to their preference or, when no
preference had been expressed, randomly assigned to
the intervention or control group. Randomization oc-
curred by means of simple randomization using a lottery
method conducted by an external person not involved in
the study.
Finally, the residents living in the intervention and
control SHOs received both written and oral informa-
tion about the study. The written information consisted
of a detailed explanation of the study and an informed
consent. The content of these documents was also orally
explained to the residents by the mental health nurses.
Development of the materials
The theoretical framework for the intervention is based
on elements of social-cognitive theory [26], self-
determination theory [27], and control theory [28]. The
intervention was developed using the mediating variable
approach including the mediating variables of know-
ledge, attitude, skills, self-efficacy and motivation [26,27].
For instance, based on the social-cognitive theory, it was
decided to develop a workshop with sessions spread over
10 weeks as this stimulates interaction and exchange of
experiences among the participants and with the work-
shop leader. Based on the self-determination theory and
control theory, an emphasis was put on the motivation to
change lifestyle through discussions on the advantages
and disadvantages of healthy eating and PA on quality of
life and long term health benefits. Individual support was
also available and participants were stimulated to define
specific personal goals for eating habits (for example: eat-
ing less energy dense food) or engaging in PA. These per-
sonal goals could be further discussed and followed up
with the nurses.
A detailed staff manual was developed based on the
manual ‘Health promotion on well-balanced eating and
healthy physical activity’ developed by the Flemish Insti-
tute of Health Promotion and Disease Prevention [29].
The target population of this manual was the general
population. For this reason, some adjustments were
made to the manual to better meet the needs of our
study population (e.g. how to live a healthier lifestyle
despite the presence of barriers associated with the MD
such as the sedative effects of certain psychotropic drugs).
The manual was built around ten themes regarding PA
and healthy eating: 1) PA and healthy eating: Introduction;
2) Awareness of the consumption of fat and fibres; 3) A
healthy lifestyle: advantages and barriers; 4) The Active
Food Triangle; 5) Using the Active Food Triangle
throughout the day; 6) Label reading; 7) The influence ofthe environment & Budget issues; 8) & 9) Physical activity;
10) A quiz on PA and healthy eating.
Implementation of the intervention
All sheltered housing organisations in the intervention
group were visited by one member of the research team
(NV). The aim of the visit was to instruct the mental
health nurses who would be offering and supervising the
group-based sessions. During a 2-hour training session
they received background information about the burden
of obesity in individuals with MD and the importance of
health promotion targeting PA and healthy eating, and
were instructed how to use the staff manual and how to
organise the walking sessions. Other staff members were
also asked to attend this training session because informa-
tion and instructions concerning the “individual support”
was also provided. The nurses were instructed to provide
individual support to all the participants during the
10-week health promotion intervention. To minimize
the workload for the nurses, they were asked to pro-
vide this individual support during their weekly meet-
ing with the resident. During the 10-week intervention,
the nurses could contact one of the researchers by
phone or by e-mail if necessary.
Study duration and intervention components
The study period consisted of an intervention period of
10 weeks followed by a post-intervention period of 24
weeks. In addition to treatment as usual, the interven-
tion group received the 10-week health promotion
programme, while the control group received only treat-
ment as usual. The programme was delivered by one or
more mental health nurses working in the intervention
SHOs. All participants received the same information in
the same format comprising the following components:
 Psycho-educational and behavioural group sessions
A weekly group session including discussions on PA
and healthy eating, problem solving, written
exercises, quizzes and plans to increase PA levels
and to stimulate healthier eating behaviour.
 Supervised exercise
In the same 10-week period a weekly 30-minutes
supervised walking session was organised.
 Individual support
During the 10-week intervention period, the
participants in the intervention group received
individual support from the mental health nurses.
These sessions lasted about ten minutes and the
following issues were discussed: (i) “Did you
understand what was discussed during the group-
based sessions?”, (ii) “How difficult was it for you to
follow the advice given during the sessions?”, and
(iii) “What made it difficult for you to follow the
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were also asked to inform the participants about the
practical issues concerning the next session such as
date, time and location.Sample size calculation
The sample size calculation was based on an average
change of the primary outcome body weight of 3.5 kg
between the intervention and control group at the end
of the study. This change was based on the results of a
literature review performed by the research team [30].
Cluster randomized trials require larger sample sizes
than the individually randomized design because obser-
vations on individuals in the same cluster tend to be cor-
related, and so the effective sample size is less than the
total number of individual participants. This reduction
in effective sample size and the degree of correlation
within clusters is expressed as the intraclass correlation
coefficient (ICC) [31]. The ICC can be interpreted as the
proportion of group-level variance compared to the total
variance. As no ICC for this kind of intervention in
people with MD was found in the literature, an assump-
tion was made by multiplying the sample size by a de-
sign factor of 1.5 [32]. A sample size of 371 individuals
in each group provided a sample size large enough to
detect a difference in mean body weight change of 3.5
kg across the two groups with 80% power at a signifi-
cance level of 0.05.
Data collection and outcome measurements
Sociodemographics
Participants were asked to complete a sociodemographic
questionnaire on sex, age, duration of stay in sheltered
housing, marital status, occupational status, contacts
with relatives, tobacco and alcohol use, and medication
use.
Primary outcome measures
The primary outcomes of the study consisted of changes
in body weight, Body Mass Index (BMI), waist circum-
ference (WC) and fat mass. Body weight and fat mass
were measured in all participants wearing light clothing
without shoes using a TANITA BC-420 SMA digital
weighing scale (TANITA, Tokyo, Japan). The measure-
ment had to be taken with bare feet as the equipment
sends a weak electrical current through the body to
measure impedance (electrical resistance) of the body.
Fat within the body allows almost no electricity to pass
through. The degree of difficulty with which electricity
passes through a substance is known as the electrical re-
sistance, and the percentage of fat can be inferred from
measurements of this resistance. To prevent a possible
discrepancy in measured values, participants had to keep
still during measurement. Height was measured in astandardized way using a Seca 225 stadiometer
(Seca GmbH & KG, Hamburg, Germany). BMI was
calculated by dividing the body weight in kilograms by
the square of the height in meters. WC was measured
with a Seca 200 tape (Seca GmbH & KG, Hamburg,
Germany) according to the ‘Clinical guidelines on the
identification, evaluation, and treatment of overweight
and obesity in adults’ [33]. All measurement proce-
dures were conducted by a member of the research
team. Both the stadiometer and the weighing scale
were placed on a flat surface to assure correct meas-
urement of the outcomes.
Secondary outcome measures
Changes in PA were assessed using the Dutch version of
the self-administered International Physical Activity Ques-
tionnaire (IPAQ), which has been shown to be a reliable
and valid PA measurement tool [34]. PA levels were also
assessed with pedometers using the Yamax Digiwalker
SW-200 (Yamax, Tokyo, Japan), as this is known to be ac-
curate and reliable for counting steps [35]. Participants
were asked to fill out the number of daily steps during
seven consecutive days on a pre-printed document. If ne-
cessary they were assisted by a mental health nurse. The
dietary habits of the participants were assessed using an
adapted version for adults of an online dietary assessment
tool, the ‘Young Children’s Nutrition Assessment on the
Web’ [36]. Dietary data were collected for two non-
consecutive days, one week day and one weekend day. In
this tool, each day is distributed in 24 possible eating occa-
sions. The participants were asked to report each food
and beverage intake to the nearest hour of the day. For
each eating and beverage occasion, the participant se-
lected the foods consumed from a hierarchically organised
menu structure, with both the interviewer and the partici-
pant sitting in front of the computer screen. Pictures [37]
and measurement units (e.g. a spoon, a small bottle) were
used to assess portions and portion sizes. For the present
analysis all food was grouped into 13 food groups. Health-
related quality of life (HRQOL) was examined using the
SF-36 Health Survey Questionnaire [38]. Psychiatric
symptom severity was assessed using the Brief Symptom
Inventory (BSI) [39]. This questionnaire is considered a
reliable and valid tool, useful in patient groups with differ-
ent psychiatric diagnoses [40].
Data on all primary and secondary outcomes were col-
lected at baseline and at ten weeks. At the end of the study
(at 36 weeks) data on body weight, WC and fat mass were
collected and BMI was calculated. At that time, participants
were also asked to complete the SF-36 questionnaire again.
Data analysis
Depending on the distribution of the quantitative vari-
ables, the independent samples T-test or the Mann
Verhaeghe et al. BMC Public Health 2013, 13:657 Page 5 of 14
http://www.biomedcentral.com/1471-2458/13/657Whitney U Test were used to compare the intervention
and control group at baseline. The X2-test was used in
qualitative variables.
First, change scores for the primary outcomes of body
weight, BMI, WC, and fat mass from baseline to the end of
the intervention period (at ten weeks) and from baseline to
the end of the study (at 36 weeks) were computed. Next,
an intention to treat (ITT) analysis using the independent
samples T-test was performed to evaluate differences in
the change scores between intervention and control groups
in the primary outcome variables from baseline to 10
weeks and from baseline to 36 weeks. ITT analysis in-
cluded all participants with baseline data. Missing data at
10 and 36 weeks were imputed with the mean change in
the primary outcomes in the control group [41]. Univariate
analyses of covariance were used to control for sex, age, liv-
ing situation, smoking habits, alcohol use, psychotropic
medication use, and duration of stay in sheltered housing.
Additional linear mixed model analysis was performed to
take possible clustering effects into account because of the
fact that individuals were nested within SHOs. For all pri-
mary outcomes, an ICC below 5% was found indicating a
limited group-level variance compared to the total variance
[42]. In addition, in all participating SHOs the number of
residents that agreed to participate was limited to 23 or
fewer individuals per SHO. This is less than the ‘30/30 rule’
as suggested by Hox [42]. It is suggested that researchers
should strive for a sample of at least 30 groups with a least
30 individuals per group. For these reasons, it was decided
to omit mixed model analysis.
To examine whether changes in the primary outcomes
were different between participants in the intervention
group who completed the health promotion programme
(i.e. individuals who attended at least 8 of 10 sessions),
those who did not and the controls, a per protocol ana-
lysis was performed within the subsample of participants
for whom baseline data and data at 10 weeks were avail-
able. A Tukey post hoc comparison test was performed
to assess whether significant treatment differences be-
tween the three groups occurred.
Analyses of the secondary outcomes were based on
computed change scores from baseline to the end of the
intervention (at ten weeks). Secondary outcome variables
were evaluated per protocol using the independent sam-
ples T-test or the Mann Whitney U Test depending on
the distribution of the quantitative variables to examine
differences between the intervention and control groups
in changes in these outcomes. A P-value ≤ .05 was consid-
ered statistically significant. For statistical analysis, the
SPSS®19 statistical software package was used.
Ethics
Permission to perform the study was obtained from the
Ethics Committee of the University Hospital of Ghent(Belgium). Written consent for participation was obtained
from all participants. If necessary, the mental health nurse
explained the contents of the informed consent document
to the candidate, but all candidates had the capacity to
consent. Participation in the study was voluntary and all
participants were informed that the data analysis would be
anonymous and that they could withdraw from the study
at any time.
Results
Recruitment process and participation rate
In Figure 1 an overview is provided of the recruitment
process and participation rate. Twenty-five SHOs agreed
to participate, accounting for 59.5% of the total number
of SHOs in the Flanders region. Fourteen of these
expressed a preference to serve as intervention group,
while five preferred to serve as control group. Six had
no preference and were randomly assigned to the inter-
vention group (n=2) or to the control group (n=4). In
one SHO serving as control group, no residents were in-
terested in participating. On the individual level, 324 res-
idents were willing to engage in the study, 225 and 99
candidates in the intervention and control SHOs re-
spectively. Based on the number of approved places in
the participating SHOs, a response rate of 24% in the
intervention group and 21% in the control group was
obtained.
Eleven candidates were excluded because of age (n=2),
cognitive impairments (n=4), having a gastric ring (n=1),
or the impossibility of being weighed using the digital
weighing scale (n=4). Of these last, three had a pace-
maker, and one had an artificial limb. Twenty-nine
(9.3%) of the remaining 313 candidates withdrew from
the study prior to the baseline measurement. Prior to
the baseline measurement a higher proportion of indi-
viduals in the control group withdrew from the study
(13.5% vs. 7.4%). Dropout rates at ten and 36 weeks were
similar in the two groups. From baseline to the end of
the study, the most common reasons for withdrawal
were no further interest or motivation (n=60), admission
to a psychiatric inpatient facility (n=9), and discharge
from sheltered housing (n=8). Two-hundred and one in-
dividuals in the intervention group and 83 in the control
group were included in the ITT analysis.
Baseline assessment
At baseline, the only significant differences observed be-
tween the intervention and control group for the
sociodemographic variables were for ‘living situation’, and
‘duration of stay in sheltered housing’ (Table 1). A higher
proportion of controls was living together than those in
the intervention group (81.0% vs. 62.0%, p=0.002). Median
duration of stay in sheltered housing was significantly lon-
ger in participants in the intervention group than in the
Sheltered housing (n=25)
- Preference I-group (n=14)
- Preference C-group (n=5)
- No preference (n=6)
Intervention group (n=16)
- Preference (n=14)
- Ad random (n=2)
Control group (n=9)
- Preference (n=5)
- Ad random (n=4)
99 candidates
I-group T0 (n=201)
1 SHO: no candidates
225candidates
Excluded: n=8 Excluded: n=3 
217candidates 96candidates
Drop out: n=16 (7.4%) Drop out: n=13 (13.5%)
C-group T0 (n=83)
Drop out: n=41 (20.4%) Drop out: n=17 (20.5%)
I-group T1 (n=162) C-group T1 (n=66)
Drop out: n=39 (24.1%) Drop out: n=16 (24.2%)
I-group T2 (n=123) C-group T   (n=50)2
Figure 1 Health promotion intervention: Recruitment process.
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medication use was found to be significantly different be-
tween the two groups for only the SGAs (p=0.03). Fifty-
eight point six per cent and 66.7% of the participants in
the intervention and control group respectively were daily
smokers. Sixty-eight point two per cent of the participants
in the intervention group were on SGA prescription com-
pared to 54.2% in the control group. At baseline, a mean
BMI of 30.2 kg/m2 and 29.5 kg/m2 was observed in the
intervention group and control group respectively. No sig-
nificant differences existed at baseline between the inter-
vention and control group regarding the primary outcome
measures (Table 2), nor were any found regarding the sec-
ondary outcome measures, except for the food groups soft
drinks (p= 0.04) and meat, fish and eggs (p= 0.04) (Tables 3
and 4).
Changes in primary outcomes
Using independent samples t-tests, significant differences
between the intervention and control group in changes in
the primary outcomes body weight (−0.35 vs. 0.22 kg,
p=0.04), BMI (−0.12 vs. 0.08 kg/m2, p=0.04), WC (−0.29
vs. 0.55 cm, p<0.01) and fat mass (−0.99 vs. −0.12%,
p<0.01) from baseline to ten weeks were found. From tenweeks to the end of the study period, the decrease in the
primary outcomes in the intervention group disappeared,
with the exception of “fatmass” (33.76 vs. 34.17%). End point
weight (88.28 vs. 87.95 kg), BMI (30.33 vs. 30.22 kg/m2) and
WC (106.32 vs. 106.16 cm) were again slightly above the
baseline values.
Univariate analyses of covariance were performed for
changes in the primary outcomes from baseline to ten
weeks controlling stepwise for the variables of sex, living
situation, smoking habits, alcohol use, SGA drug use,
age and duration of stay in sheltered housing. The sig-
nificant differences between the intervention and control
group in changes in weight and BMI disappeared when
controlling for duration of stay in sheltered housing
(weight: F=2.976, p=0.086; BMI: F=2.820, p=0.094) and
SGA drug use (weight: F=3.023, p=0.083; BMI: F=2.997,
p=0.085), while it remained significant for changes in
WC (stay: F=6.214, p=0.013; SGA: F=6.286, p=0.013)
and fat mass (stay: F=6.544, p=0.011; SGA: F=7.076,
p=0.008). In the intervention group, a trend was found for
a positive relation between duration of stay and weight
loss. Participants who had already been staying longer in
sheltered housing lost more weight (Spearman’s ρ =−0.11,
p=0.08).
Table 1 Baseline sociodemographic data
Variable Intervention
group (n=201)
Control
group (n=83)
p
Sex, n (%) 0.27§
men 119 (59.2) 55 (66.3)
women 82 (40.8) 28 (33.7)
Age (years), mean±SD 46.2±12.5 46.6±11.9 0.83‡
Smoking, n (%)
no smoking 77 (41.4) 26 (33.3) 0.22§
smoking 109 (58.6) 52 (66.7)
Alcohol use, n (%)
regular 87 (46.5) 35 (44.9) 0.81§
never 100 (53.5) 43 (55.1)
Employment, n (%) 0.51§
regular 11 (5.9) 2 (2.5)
sheltered 73 (39.2) 32 (40.5)
no employment 102 (54.8) 45 (57.0)
Living situation, n (%) <0.01§
alone 71 (38.0) 15 (19.0)
with others 116 (62.0) 64 (81.0)
Contact with family, n (%) 0.70§
regular 134 (72.0) 58 (74.4)
seldom/never 52 (28.0) 20 (25.6)
Contact with friends, n (%) 0.12§
regular 111 (60.0) 54 (70.1)
seldom/never 74 (40.0) 23 (29.9)
Stay in SH (years),
median (range)
4.4 (0.1-22.3) 2.5 (0.1-16.3) 0.04†
DSM-IV diagnosis, n (%)
schizophrenia 80 (41.2) 25 (30.1) 0.08§
mood disorder 44 (22.7) 24 (28.9) 0.27§
substance misuse 30 (15.5) 14 (16.9) 0.77§
personality disorder 29 (14.9) 11 (13.3) 0.71§
other 11 (5.7) 9 (10.8) 0.13§
Medication, n (%)
sedatives/anxiolytics 60 (29.9) 34 (41.0) 0.07§
first generation
antipsychotics
46 (22.9) 13 (15.7) 0.17§
second generation
antipsychotics
137 (68.2) 45 (54.2) 0.03§
antidepressants 106 (52.7) 46 (55.4) 0.68§
§Pearson Chi-Square; ‡ Independent samples t-test; †Mann–Whitney U test;
SH Sheltered Housing.
DSM-IV Diagnostic and Statistical Manual of Mental Disorders.
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performed for changes in the primary outcomes from
baseline to ten weeks, controlling simultaneously for
sex, living situation, smoking habits, alcohol use, SGA
drug use, and duration of stay in sheltered housing. Thesignificant differences between the intervention and con-
trol group in changes in weight (F=3.199, p=0.075) and
BMI (F=3.084, p=0.08) disappeared, while it remained
for WC (F=6.122, p=0.014) and fat mass (F=8,650,
p=0.004) (data not shown).
Changes in secondary outcomes
In Tables 3 and 4 the changes in the secondary outcomes
from baseline to ten weeks are summarized. Differences be-
tween the intervention and control group in changes in the
secondary outcomes from baseline to ten weeks were only
significant for the variable of pedometer determined steps/
day (p= <.001). Mean steps per day increased in the inter-
vention group (1256±1933 steps/day), while the number of
daily steps in the control group decreased (−426±2754
steps/day). Soft drink intake in the intervention group was
decreased at ten weeks (−50.8 g/day), while this was in-
creased in the control group (64.2 g/day). This latter differ-
ence between the two groups, however, not statistically
significant (p= 0.14). No intervention effect was observed
for the other PA variables, food intake, HRQOL and psy-
chiatric symptom severity.
Adherence to the intervention
A per protocol analysis using analysis of variance was
performed to examine the differences in the primary
outcomes from baseline to the end of the intervention
(at ten weeks) in participants who completed the
programme, those who did not, and controls. Com-
pleters were defined as individuals in the intervention
group who attended at least 8 of 10 sessions (51.2%). In
the intervention group, a larger decrease in the primary
outcomes was found in those who completed the
programme than in those who did not (Table 5). Signifi-
cant differences were found between completers and
controls in changes in body weight (−0.72 vs. 0.22 kg,
p=0.03), BMI (−0.23 vs. 0.08 kg/m2, p=0.04), WC (−0.64
vs. 0.55 cm, p<0.01), and fat mass (−1.33 vs. 0.05%,
p<0.01), but not between non-completers and controls.
Participants who completed the programme were signifi-
cantly less likely to smoke than the non-completers
(44.9 vs. 72.7% smokers, p<.001). Compared with those
in the intervention group who did not complete the
programme, mean age in completers was borderline sig-
nificantly higher (48.9±11.7 vs. 44.9±12.9 years, p=0.051).
All participants in the intervention group who lost at least
five per cent of their baseline body weight completed the
intervention (10.7%). Thirteen per cent of the completers
lost between four and five per cent of their initial body
weight (data not shown).
Discussion
The aim of the study was to examine the effectiveness of a
health promotion intervention targeting PA and healthy
Table 2 Baseline assessment and changes in primary outcomes from baseline to 10 and 36 weeks (ITT)
Variable Intervention
group (n=201)
Control
group (n=83)
Between
group change
p‡
Weight (kg), mean±SD
baseline 87.95±20.74 85.19±16.04 0.23
at 10 weeks 87.60±20.77 85.41±16.49
change at 10 weeks −0.35±2.15 0.22±2.14 0.57 0.04
≥ 5% weight loss, n (%) 11 (5.5%) 3 (3.6%)
at 36 weeks 88.28±21.03 86.18±16.99
change at 36 weeks 0.33±3.51 0.99±3.01 0.66 0.14
BMI (kg/m2), mean±SD
baseline 30.22±6.14 29.52±5.41 0.37
at 10 weeks 30.10±6.18 29.60±5.56
change at 10 weeks −0.12±0.75 0.08±0.78 0.20 0.04
at 36 weeks 30.33±6.26 29.87±5.74
change at 36 weeks 0.11±1.23 0.35±1.05 0.24 0.14
Waist (cm), mean±SD
baseline 106.16±16.81 105.21±14.39 0.65
at 10 weeks 105.87±16.73 105.76±14.72
change at 10 weeks −0.29±2.18 0.55±2.61 0.84 <0.01
at 36 weeks 106.32±16.82 106.43±15.10
change at 36 weeks 0.16±3.41 1.22±3.53 1.06 0.02
Fat mass (%), mean±SD
baseline 34.17±10.55 33.37±10.63 0.57
at 10 weeks 33.18±10.62 33.25±10.72
change at 10 weeks −0.99±2.51 −0.12±1.60 0.87 <0.01
at 36 weeks 33.76±11.21 34.56±11.04
change at 36 weeks −0.41±3.57 1.19±2.58 1.60 <0.001
‡ Independent samples t-test.
ITT, intention to treat; kg, kilogramme; BMI, Body Mass Index; cm, centimetre.
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http://www.biomedcentral.com/1471-2458/13/657eating in individuals with MD living in sheltered housing.
The study period consisted of a 10-week intervention
period followed by a 6-month follow up period.
From baseline to the end of the intervention period (at
ten weeks), significant differences in changes in body
weight, BMI, WC, and fat mass between the intervention
and control group were observed. In the intervention
group, a decrease in these outcomes was found, while
they increased in the control group. For WC and fat
mass, this intervention effect was independent of
confounding variables. Within the intervention group, a
larger decrease in weight, BMI, WC, and fat mass was
found in those who completed the intervention than
those who did not. From baseline to the end of the
study, the decreases in the intervention group in the pri-
mary outcomes disappeared, except for the outcome of
fat mass. From baseline to the end of the intervention
period, a significant difference between the intervention
and control group was observed for the pedometer-determined steps/day. In the intervention group, the
mean number of daily steps increased, while it decreased
in the control group. No other significant differences be-
tween the intervention and control group in changes in
the secondary outcomes were found.
The baseline characteristics demonstrated the un-
healthy lifestyle behaviour of the study population. For
example, a mean BMI of 30 kg/m2 was found in our
study population, compared with a mean BMI of 25.3
for the general population in Belgium [43]. Smoking
prevalence in the study population also greatly exceeded
that of the general population in Belgium. Amongst the
study population, about 60% were daily smokers, while
in the general population it is about 21% [43].
It is well established that individuals with MD are at a
greater risk of being overweight or obese than the general
population [2,3]. Important reasons for this high preva-
lence consist of the use of SGAs [9], lower PA levels
[10,11] and unhealthy eating habits [15,17]. It is therefore
Table 3 Baseline assessment and changes in secondary outcomes from baseline to 10 weeks
Variable Intervention group Control group Between group change p
Total PA1 (METmin/week), mean±SD
baseline 3282±3118 3770±3071 0.20†
at 10 weeks 4992±5089 4497±4586
change 1709±4430 727±4887 982 0.17‡
Moderate PA1 (METmin/week), mean±SD
baseline 1568±1990 2061±2334 0.07†
at 10 weeks 2518±3026 2346±3479
change 950±2849 285±3842 665 0.19‡
Vigorous PA1 (METmin/week), mean±SD
baseline 486±2036 311±853 0.74†
at 10 weeks 979±2992 591±1559
change 493±2445 279±1619 214 0.54‡
Walking PA1 (METmin/week), mean±SD
baseline 1228±1441 1398±1564 0.44†
at 10 weeks 1495±1617 1560±1687
change 266±1988 163±2096 103 0.74‡
Pedometer2 determined steps/day, mean±SD
baseline 6872±3585 7215±3368 0.61‡
at 10 weeks 8128±4050 6788±3507
change 1256±1933 −426±2754 1340 <0.001‡
SF36 PCS3, mean±SD
baseline 40.4±7.7 41.2±5.9 0.51‡
at 10 weeks 39.4±7.5 40.2±7.8
change −0.9±8.5 −1.0±7.6 0.1 0.96‡
SF36 MCS3, mean±SD
baseline 35.6±8.7 35.8±7.9 0.89‡
at 10 weeks 34.8±7.9 35.3±7.4
change −0.9±7.6 −0.5±6.8 0.4 0.77‡
BSI_PST4, mean±SD
baseline 27.6±12.6 26.5±13.8 0.60‡
at 10 weeks 25.3±12.8 24.0±14.5
change −2.4±9.5 −2.5±7.5 0.1 0.92‡
PA, physical activity; PCS, physical component score; MCS, mental component score; BSI_PST, Brief Symptom Inventory Positive Symptom Total.
1Intervention group, n=127; Control group, n=60; 2 Intervention group, n=92; control group, n=40; 3Intervention group, n=112; control group, n=51; 4Intervention
group, n=116; control group, n=55.
‡Independent Samples T-test, †Mann Whitney U test.
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portance of health promotion interventions targeting PA
and healthy eating in this population. Several guidelines
already emphasized the importance of PA and healthy eat-
ing [44-46] and the relevance of health promotion in men-
tal health care is also acknowledged by the European
Psychiatric Association [47].
The results of the study demonstrate that relatively
small but significant reductions in body weight, BMI,
WC, and fat mass are possible following a 10-weekhealth promotion intervention targeting PA and healthy
eating. Previous research has shown that weight loss
through lifestyle interventions in individuals with MD is
possible. The results of these studies must, however,
interpreted cautiously due to their methodological limi-
tations such as small sample sizes or the absence of a
control group [30,48]. The results of our study are more
promising in those participants who completed the
intervention. It is also important to note that 68% of the
participants in the intervention group were taking a
Table 4 Baseline assessment and changes (mean - range) in food intake (g/day) from baseline to 10 weeks
Variable Intervention group (n=152) Control group (n=49) Between group change p
potatoes baseline 96.0 (0–472.5) 99.8 (0–332.5) 0.59†
at 10 weeks 95.3 (0–250.0) 82.6 (0–195.0)
change −0.64 −17.24 16.6 0.28‡
alcohol baseline 38.9 (0–1240.0) 38.3 (0–625.0) 0.64†
at 10 weeks 31.6 (0–1155.0) 56.0 (0–915.0)
change −7.27 17.70 24.97 0.34‡
bread & rolls baseline 133.0 (0–702.0) 141.2 (0–420.0) 0.32†
at 10 weeks 124.3 (0–360.0) 119.3 (0–283.5)
change −8.73 −21.97 13.24 0.38‡
soft drinks baseline 338.9 (0–2900.0) 428.1 (0–2665.0) 0.04†
at 10 weeks 288.1 (0–2150.0) 492.2 (0–2700.0)
change −50.82 64.16 114.98 0.14‡
fruit baseline 97.2 (0–1247.5) 84.1 (0–625.0) 0.65†
at 10 weeks 112.6 (0–1040.0) 73.9 (0–352.5)
change 15.42 −10.14 25.56 0.24‡
vegetables baseline 94.3 (0–690.0) 111.6 (0–1127.5) 0.96†
at 10 weeks 85.5 (0–520.0) 68.5 (0–430.0)
change −8.87 −43.05 34.18 0.23‡
coffee & tea baseline 696.4 (0–4125.0) 761.3 (0–2925.0) 0.73†
at 10 weeks 542.9 (0–2475.0) 632.9 (0–2625.0)
change −153.49 −128.36 25.13 0.78‡
milk baseline 152.6 (0–1087.5) 212.6 (0–1500.0) 0.48†
at 10 weeks 143.4 (0–1437.5) 159.4 (0–650.0)
change 319.20 −53.17 372.37 0.52‡
sweets baseline 52.4 (0–385.5) 69.5 (0–552.0) 0.05†
at 10 weeks 28.4 (0–169.0) 45.5 (0–277.0)
change −24.0 −24.0 0 0.99
water baseline 515.4 (0–2541.3) 480.3 (0–2860.0) 0.33†
at 10 weeks 478.3 (0–2212.5) 595.9 (0–2800.0)
change −37.11 115.61 152.72 0.10‡
meat, fish, eggs baseline 130.0 (0–658.0) 150.5 (0–359.0) 0.04†
at 10 weeks 148.7 (0–461.0) 139.3 (0–402.0)
change 18.19 −11.20 29.39 0.09‡
fatt & sauces baseline 53.8 (0–287.5) 54.6 (0–347.5) 0.81†
at 10 weeks 39.3 (0–215.0) 42.2 (0–140.0)
change −14.57 −12.67 1.9 0.85‡
biscuits baseline 45.0 (0–780.0) 43.8 (0–330.0) 0.82†
at 10 weeks 26.7 (0–240.0) 27.2 (0–160.0)
change −18.35 −16.60 1.75 0.91‡
‡Independent Samples T-test, †Mann Whitney U test.
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ated with weight gain in individuals with MD [8,9].
The decreases in weight, BMI, WC, and fat mass in
the intervention group disappeared in the period fromthe end of the intervention period to the end of the
study. So, although emphasis on health promotion
targeting PA and healthy eating during a certain period
of time is beneficial, it probably needs to be continued.
Table 5 Baseline assessment and changes in primary outcomes in the intervention group between completers and
controls and non-completers and controls from baseline at 10 weeks (per protocol)
Variable Completers
(n=103)
Non-completers
(n=57)
Controls
(n=66)
Δ Completers vs.
Controls
p§ Δ Non-completers
vs. Controls
p§
Weight (kg), mean±SD
baseline 88.01±19.67 90.39±21.62 83.25±14.78
at 10 weeks 87.35±19.75 90.34±21.57 83.47±15.38
change at 10 weeks −0.72±2.43 −0.05±2.27 0.22±2.40 0.95±0.38 0.03 0.28±0.43 0.80
≥ 5% weight loss, n (%) 11 (10.7%) 0 3 (4.5%)
BMI (kg/m2), mean±SD
baseline 30.29±5.67 31.11±6.38 28.87±5.12
at 10 weeks 30.04±5.74 31.09±6.40 28.95±5.32
change at 10 weeks −0.23±0.86 −0.01±0.77 0.08±0.87 0.33±0.13 0.04 0.09±0.15 0.80
Waist (cm), mean±SD
baseline 107.54±16.23 107.59±16.67 103.82±13.87
at 10 weeks 106.87±16.26 107.40±16.47 104.37±14.28
change at 10 weeks −0.64±2.41 −0.14±2.42 0.55±2.93 1.23±0.41 <0.01 0.74±0.47 0.25
Fat mass (%), mean±SD
baseline 34.82±10.30 33.70±10.09 32.55±11.01
at 10 weeks 33.41±10.57 33.04±10.09 32.60±11.13
change at 10 weeks −1.33±3.24 −0.64±2.44 0.05±2.62 1.45±0.48 <0.01 0.71±0.54 0.39
§Univariate Analysis of Variance.
kg, kilogramme; BMI, Body Mass Index; cm, centimetre.
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alongside other treatment aspects such as psychological
and medication treatment, into the daily care of individ-
uals with MD should be considered. Lifestyle interven-
tions are essential in lowering the risks and morbidity
associated with obesity and should be integrated into the
daily care of individuals with MD [49,50].
All mental health nurses involved in the study received
the same training by one (the same) member of the research
team. They received detailed instructions concerning the de-
livery of the group-based sessions as well as how to support
the participants individually. The aim was to obtain as much
consistency as possible concerning the information pro-
vided. We are, however, aware that the views and attitudes
of individual nurses towards PA and healthy eating may to
some extent have influenced the way in which they commu-
nicated with the participants.
The design of evaluation studies of public health inter-
ventions, like health promotion programmes, poses sev-
eral problems and they require multiple, flexible, and
community-driven strategies [51]. Randomization at the
individual level may cause contamination bias if individ-
uals in the control group receive some aspects of the
intervention by being in proximity to individuals in the
intervention group [52,53]. To avoid the risk of contam-
ination bias arising from the fact that participants in the
intervention and control group could be living together
in the same SHO, it was decided to use a cluster designwith the SHO as the unit of clustering. It was assumed
that if SHOs were assigned to a non-preferred study
arm, they could be disappointed and their interest in
participating in the study could be reduced as a result
[23,54]. A substantial risk of non-participation on the
SHO-level was also assumed based on the results of previ-
ous qualitative research which has identified lack of time
due to the high workload in the daily care of patients with
MD as a common barrier for mental health nurses to en-
gage in health promotion programmes [55,56]. For these
reasons, a preference design appeared to be appropriate.
As far as is known to the authors, this is the first trial
examining the effectiveness of a health promotion inter-
vention using a cluster preference RCT design.
Besides the significance of the results it is also import-
ant to consider their clinical relevance. According to the
UK Department of Health [57], reductions in body
weight of 5% or more are considered to greatly reduce
the risks of physical health problems. At the end of the
intervention period (at ten weeks), only 5.5% of the par-
ticipants in the intervention group reached this target.
Among those who completed the intervention, however,
the figure jumps to 10.7% with a further 13% losing be-
tween four and five per cent of their body weight. To
our opinion, integrating PA and healthy eating into the
daily care of individuals with MD has the potential to in-
crease the number of them losing at least 5% of their
body weight.
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healthy physical activity” program [29] served as the
basis for that used in our study. The use of this
programme appeared reasonable to us as its target popu-
lation consists of the general population in the Flanders
region (Belgium). Some adjustments were made to it to
better meet the needs and interests of the population of
individuals with MD included in our study. At this point,
it is important to emphasize that, as far as is known to
the authors, the efficacy of this general population
programme has not been tested, resulting in no informa-
tion on possible effect size. For this reason, the sample
size calculation for our study was performed using a be-
tween group change of 3.5 kg found in a systematic re-
view we performed [30]. The mean between group
change of 0.57 kg found in our study was yet to a large
extent lower as the change of 3.5 kg. To our opinion,
two possible explanations for the deviation between the
weight loss of 3.5 kg found in our review and the
amount of weight loss of 0.57 kg found in our study
exist. First, the larger amount of weight loss found in the
review may be explained by the fact that all but two of
the fourteen studies reviewed consisted of an interven-
tion duration in excess of the 10-week intervention
period of our study (range: 2 – 12 months). Second, the
studies included in the review consisted of a psycho-
educational and/or behavioural intervention. In seven of
them, this was combined with supervised exercise. Add-
itionally, in some studies, the intervention also included
restricted energy intake/ energy expenditure. This may be
a second explanation for the larger amount of weight loss
observed in the review. The health promotion programme
assessed in our study did not include individualized energy
restriction or energy expenditure goals such as low fat or
low calorie diets. Based on the results of previous qualita-
tive research [58], it was assumed that such an interven-
tion would be too demanding for both the patients and
the mental health nurses. Further research is required to
examine the long-term effects of such an intervention (for
example: providing the intervention twice a year, interven-
tion with a longer duration).
The sample size calculation, identified that 371 indi-
viduals in each group were needed. This sample size was
not reached as only 201 individuals in the intervention
group and 83 in the control group agreed to participate.
This number represents about only 20 per cent of the
individuals living in these settings in the Flanders region,
which places a limitation on the generalizability of the
findings to the wider population of individuals living in
sheltered housing. Compared with the most recent avail-
able data from the Federal Public Service of Health [59]
on the sheltered housing population in the Flanders
region, our study population had a higher proportion
of women (39 vs. 30%), mean age was slightly lower(46.3±12.3 vs. 50.0±13.0 years), and it was more fre-
quently diagnosed with mood disorders (25 vs. 16%).
Data on the duration of stay in sheltered housing (4 vs.
4.2 years) and the proportion of individuals with schizo-
phrenia (38 vs. 39%), substance misuse (16 vs. 18%), and
personality disorders (14 vs. 12%) were comparable [59].
The study sample was characterized by high drop out
rates. At the end of the study, 40% of the participants in
both the intervention and control group were lost to
follow-up. The main reason for dropping out was no fur-
ther interest or motivation to participate. This is congru-
ent with the results of previous research on barriers to
individuals with MD engaging in health promotion activ-
ities which report lack of motivation and energy as a
consequence of the MD and side effects of psychotropic
drug use like sedation [60-62].
Another element of concern was the high number of
individuals who did not fill out the various question-
naires at the end of the intervention period. This was re-
lated to the considerable drop-out rates from the study
as a result of the lack of further interest and/or motiv-
ation to participate. For example, only 56% in the inter-
vention group and 61% in the control group filled out
the SF36 Health Survey questionnaire at the second
measurement at ten weeks. Only 46 and 48 per cent of
the participants in the intervention and control group
respectively registered the number of daily steps during
the second registration period (at ten weeks). For this
reason, the promising results of the increase in steps/day
from baseline to the end of the intervention period must
be interpreted cautiously.
We are aware that omitting mixed model analysis is
another limitation of the current study. The decision to
omit mixed model analysis was based on the fact that a
limited group-level variance compared to the total vari-
ance was present. For all primary outcomes, an ICC
below 5% was found, indicative of a low level of variance
at the level of the SHOs [42]. Moreover, the number of
participating SHOs and the number of individuals per
SHO was below the minimum number of groups and in-
dividuals recommended for mixed model analysis [42].
We nevertheless performed unadjusted mixed model
analysis to examine whether the SHO clustering had an
impact on the intervention effect for the primary out-
comes from baseline to the end of the intervention at
ten weeks. The significant differences between interven-
tion and control group in changes in body weight
(p=0.111) and BMI (p=0.109) disappeared, while they
remained significant for WC (p=0.006) and fat mass
(p=0.013) (data not shown). No ICC related to health
promotion programmes with a cluster randomized con-
trolled design in individuals with MD was found in the
literature. To account for the degree of correlation
within the several clusters in our study, the calculated
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the ICC, no design factor for the type of intervention
assessed in our study was found in the literature. So, an
assumption was made based on a design effect of 1.5
used in previous studies [32,63].
The target population of our study comprised individ-
uals with a wide variety of psychiatric diagnoses such as
schizophrenia, mood disorders, and personality disor-
ders. From a methodological point of view it may have
been more suitable to focus only on individuals with a
specific diagnosis, which would probably have lead to
different results. However, it has already been well
established that overweight and obesity affects individ-
uals with MD irrespective of their specific psychiatric
diagnosis [1,64,65]. In this sense, health promotion
targeting PA and healthy eating appears to be important
and desirable for individuals with MD independent of
their diagnosis. In any case, sheltered housing is aimed
at individuals with a wide variety of mental health prob-
lems. For these reasons, it was decided to include indi-
viduals irrespective of their diagnosis in the study
population. Further research is nevertheless required to
examine the effects of this kind of intervention in indi-
viduals with a specific psychiatric diagnosis.
Conclusions
In conclusion, the study described in this paper has shown
that small significant improvements in body weight, BMI,
WC, and fat mass are possible in individuals living in shel-
tered housing following a psycho-educational, behavioural
and exercise group-based intervention. The results are
more promising in those participants who completed the
intervention. The results of the present study emphasize
the need to integrate lifestyle counselling into the daily care
of individuals with MD in order to lower the risk of serious
somatic diseases including CVD and type 2 diabetes. Add-
itional controlled trials of longer duration are necessary in
order to examine the long-term effects of maintained
health promotional efforts. In this context, research on the
optimal “intervention dose” in terms of acceptability, ef-
fectiveness and cost-effectiveness of the intervention is also
required. Further research is additionally required to exam-
ine the effectiveness of such programmes in other settings,
for example inpatient settings, and under other conditions
such as group-based versus individually-based interven-
tions or programmes limited to individuals with BMI>25
kg/m2 or on the same medication regimen. Finally, in view
of the high drop-out rates in our study population, further
research is also needed to examine the most effective ways
to motivate individuals with MD to participate and persist
in health promotion programmes.
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